Inserting a Short Peripheral Catheter (SPC) into the patient veins likely to be the most practiced procedure in a hospital environment. Whenever a SPC is introduced into a patient the risk of an extra lumen infection is present, as the catheter piercing the human skin allows for bacteria and pathogens to make their way into the bloodstream. Other factors, such as bad asepsis during the SPC’s manipulation increases the chances of infection as well. (1, 2)
An infection caused by the insertion of SPCs increases the patient’s hospital stayfrom seven days up to twenty days, in addition to the substantial economic costs accrued by the hospital. For example, in the United States, such a procedure cancost up to forty-eight thousand dollars. (1)
Introducing SPCs increases the risk of Healthcare-Associated Infections (HAI), as doing so breaches the skin’s continuity solution and its protection function is therefore altered due to permanent microflora accessing the bloodstream. The HAIcausedby inserting SPC are complex and varied, especially when using antibiotics, asthese damage the vein walls.This means there are several sources for SPC contamination: the resident microbial flora of the patient, the tip of SPC that gets contaminatedwhen puncturing, contamination of the lines, shutters and bad hand hygiene of health professionals. (3)
Phlebitis in its turn is an inflammatory process of the intimate tunica, the most internal wall of the veins made of endothelial tissue, and the most complicatedin terms of SPCs’ use. The SPC predisposes the development of phlebitis and venous stasis along with the formation of blood clots that may migrate to the bloodstream and form thrombophlebitis therein. The vascular net is a sensible structure and multiple attempts to introduce a SPC compromises the short and long term success rateof obtaining new venous accesses. It is estimated that a quarter of all SPCs inserted get obstructed or accidentally removed, which can lead to extravasation of the solution to be infused with edema formation. Physically, although there is no agreement within the scientific community, it is characterized by local redness, swelling, pain, heat, and formation of a palpable venous cord along the vein. (1–6)
Phlebitis can also be classified according to its etiology: (a) mechanic, related to the fabrication material of SPCs, improper fixing and incorrect handling of the SPCs during its use; (b) chemical: caused by the substance to be infused, such as some antibiotics, example - vancomycin and ceftriaxone - are aggressive to the endothelial wall; (c) bacterial: when there is microbial colonization due to lack of asepsis, either from the patient or health professional or even from non-optimization regarding the access itself; finally (d) post-infusion: between 48 hours to 96 days after removal, there is risk of developing phlebitis. (7)
The North American Infusion Nursing Society, a group of Nurses who regulate and publish guidelines and standards aiming to achieve the best practices dealing with infusion therapy, defined the acceptable limit for the incidence of phlebitis to be equal to or less than 5%. Notwithstanding, the care provided in several hospitals and clinics all around is different. (8)
In an enquiry performed by Nobre (9), the observer team stated that in 221 observations related to 78 SPCs introduced in 58 patients worldwide, the incidence of phlebitis was 36.7%. In another study conducted by Urbanetto et al (10), 231 further patients had a 24.7% incidence rate of phlebitis. In another study with 155 introduced SPCs, Magerote and her team (11) revealed an incidence of 25.8%.
Considering the epidemiology related to the development of phlebitis in Portugal, Oliveira(5) stated that in 19 studies focused in venous accesses, the dimension and incidence of phlebitis in Portuguese healthcare providers ranges from 3.7–64.6%. In fact, the results of the Portuguese National Infection Prevalence Survey indicate that SPC is the most relevant extrinsic factor for the occurrence of nosocomial infections in blood flow and HAI. The same enquiry applied in 2012 showed us an 11.7% prevalence rate of phlebitis due to SPC usage. (5)
Nurses in Portugal do not have a reliable and valid tool to perform SPC monitoring. Furthermore, there is no agreement on howNurses shouldrecord relevant information of SPC’s usage, by means of standardized and systematic terminology, such as the International Classification for Nursing Practice™. (12)
In order to bridge the gap between the need to have accurate records and a missing standardized system for this purpose, we propose a capable and appropriate tool, which will provide Portuguese Nurses with the help they need regarding the status quo of record taking and keeping.
Since Nurse teams are familiar with the complications of using an SPC device, phlebitis’ incidence is now seen as a quality indicator of the care provided. Therefore, the goal is to achieve an optimized practice (13).
A process of translation and cultural adaptation of the original VIP scale into European Portuguese was conducted, according to the country specifications and healthcare scenario. Also, reliability tests were performed according to data previously obtained from a representative sample. Therefore, the goal of this study is to translate and culturally adapt the VIP scale to European Portuguese in order to achieve a reliability score.